Proscia Named Global 2️⃣0️⃣2️⃣6️⃣ Best in KLAS for Digital Pathology in Europe
Proscia, a software company advancing digital pathology for pathologists, scientists, and patients, has just been awarded Global 2026 Best in KLAS for Digital Pathology (Europe), a 🔝 distinction for healthcare technology vendors (Proscia Named Global 2026 Best in KLAS for Digital Pathology in Europe). This honor recognizes Concentriq® as the enterprise platform that laboratories count on for critical diagnoses that guide patient care.
▶️ “The Best in KLAS awards recognize the vendors who consistently deliver excellence through partnership with healthcare organizations.”
▶️ “Winning this award means customers trust you to help them succeed in our rapidly changing healthcare landscape. This means helping them to improve patient care, achieve better outcomes, and find true ROI. We’re honored to amplify the voice of providers and payers at KLAS, and to celebrate those vendors who turn feedback into action."
said Adam Gale, CEO of KLAS Research. KLAS helps healthcare providers make informed technology decisions by offering accurate, honest, and impartial vendor performance information, based solely on customer feedback, evaluating vendors across six customer experience pillars: Product, Operations, Loyalty, Relationship, Value, and Culture. Each year, KLAS gathers input from thousands of healthcare providers and payers worldwide to determine the winners.
Proscia’s Concentriq scored highly with KLAS for primary diagnosis, highlighting ease of use, quality, and high-impact product releases. Customers’ trust in the platform also reflects Proscia’s dependable partnership through implementation and beyond, including responsive, proactive support that accelerates time-to-impact.
➡️ Proscia is known for offering the Concentriq® platform that delivers a uniquely comprehensive approach to AI from drug discovery to diagnostics. The platform incorporates a portfolio of best-in-class applications, tools for building algorithms, and AI-native features into routine workflows, helping its user base of over 12,000 pathologists and scientists to drive efficiencies, identify novel biomarkers, and develop and deploy companion diagnostics.
So far, Concentriq is trusted by 1️⃣6️⃣ of the top 2️⃣0️⃣ pharmaceutical companies as well as major laboratories set to diagnose 3️⃣2️⃣, 0️⃣ 0️⃣ 0️⃣ patients per day on the platform this year.
Recent Highlights 👉
✅ On December 9, 2025, New York City’s leading independent gastroenterology practice, New York Gastroenterology Associates, LLP (NYGA), started working with Proscia, a pathology AI company, and has adopted Proscia’s Concentriq® software platform to deliver fast, expert results and lay the technology foundation for capitalizing on 🆕 opportunities to fuel research breakthroughs (New York Gastroenterology Associates Taps Proscia for Digital Pathology).
✅ On October 27, 2025, Spaarne Gasthuis, a 🔝 clinical teaching hospital serving part of the Greater Amsterdam region, announced is fully digitizing its pathology practice with Concentriq® AP-Dx from Proscia (Spaarne Gasthuis to Advance its Commitment to Patient Care with Proscia’s Software).
✅ On October 15, 2025, Proscia added an AI biomarker detection tool for skin tissue to its Concentriq software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, 👉 the Cleo Skin will strengthen Concentriq’s lead in offering the industry’s broadest portfolio of AI solutions on a single platform.
✅ On September 24, 2025, Proscia introduced virtual staining in its Concentriq software platform to help laboratories reduce the costs associated with traditional chemical methods and drive efficiency in high-throughput workflows (Proscia to Expand Pathology AI Capabilities with Virtual Staining). The virtual staining, powered by Pictor Labs, will support the evolution from research applications to clinical deployment, expanding diagnostic possibilities.
✅ On September 16, 2025, Proscia announced the next step in its collaboration with Amazon Web Services (AWS) to address two of digital pathology’s most pressing challenges:
➡️ managing surging data volumes and
➡️ standardizing siloed data.
Accordingly, it has integrated its Concentriq® platform for pathology with AWS HealthImaging to provide laboratories and life sciences organizations with a cloud-native foundation, accelerating routine workflows and fueling AI-driven precision medicine initiatives (Proscia Expands AWS Collaboration to Advance Precision Medicine with AWS HealthImaging Integration).
✅ On September 8, 2025, Proscia announced Proscia Aperture™, a pioneering precision medicine solution that automatically identifies candidates at the moment of diagnosis—addressing one of healthcare’s most critical challenges.
Designed to help you reduce stress and anxiety, be creative, and stay focused, with microdosing (Lion’s Mane mushroom 🍄 and L-theanine from green tea leaves).
Clarity by Flowdose ☺️
Reduce your Stress with Micro Coffee ☕ (Delicious blend of ✅ medium roast Arabica coffee, ✅ probiotics, ✅ cacao and ✅ organic mushrooms, designed for enhanced focus, improved mood, gut health, and jitter-free energy) and Belgian Dark Chocolate 🍫 (Made with dark chocolate imported from Belgium: fast acting, clean and precise dosing).